US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.72

+0.08000.43%

Post-market: 18.720.00000.00%16:10 EDT

Volume:95.48K

Turnover:1.78M

Market Cap:110.43M

PE:- -

High:18.75

Open:18.74

Low:18.56

Close:18.64

52wk High:20.39

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:0.50

T/O Rate:1.62%

Dividend:0.72

Dividend Rate:3.82%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Is Akeso (SEHK:9926) Cheap As Its Phase III Colon Cancer Trial Expands Its Pipeline?

Simply Wall St.

Akeso Doses First Patient in Phase III Cadonilimab Perioperative Trial for MSI-H/dMMR Colon Cancer

WuXi Biologics Showcases Biomanufacturing Capabilities at CPHI Milan 2026

Innovent Announces Phase 3 Restore-3 Study of Sycume® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/KURE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.72,"timestamp":1791576000000,"preClose":18.64,"halted":0,"volume":95481,"hourTrading":{"tag":"盘后","latestPrice":18.72,"preClose":18.72,"latestTime":"16:10 EDT","volume":6,"amount":112.32,"timestamp":1791576604078,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00429184549356214,"floatShares":5899036,"shares":5899036,"eps":0,"marketStatus":"Market Closed","change":0.08,"latestTime":"10-09 16:00:00 EDT","open":18.74,"high":18.75,"low":18.5603,"amount":1784556,"amplitude":0.010177,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.64,"sharesOutstanding":4750002,"nav":18.56,"aum":113201248.34,"dividendRate":0.038237,"bidAskSpread":0.004047,"postHourTrading":{"tag":"盘后","latestPrice":18.72,"preClose":18.72,"latestTime":"16:10 EDT","volume":6,"amount":112.32,"timestamp":1791576604078,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5008975982032404,"impliedVol":0.3317,"impliedVolPercentile":0.6733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5899036,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5008975982032404,"shares":5899036,"dividePrice":0.7158,"high":18.75,"amplitude":0.010177,"preClose":18.64,"low":18.5603,"week52Low":14.3797,"pbRate":"--","week52High":20.385,"institutionHeld":0,"latestPrice":18.72,"eps":0,"divideRate":0.038237,"volume":95481,"delay":0,"ttmEps":0,"open":18.74,"prevYearClose":17.04,"prevWeekClose":19.14,"prevMonthClose":19.25,"prevQuarterClose":19.25,"fiveDayClose":19.14,"twentyDayClose":17.74,"sixtyDayClose":17.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674164688","title":"Is Akeso (SEHK:9926) Cheap As Its Phase III Colon Cancer Trial Expands Its Pipeline?","url":"https://stock-news.laohu8.com/highlight/detail?id=2674164688","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674164688?lang=en_us&edition=fundamental","pubTime":"2026-10-11 08:30","pubTimestamp":1791678653,"startTime":"0","endTime":"0","summary":"Why this Phase III move matters for Akeso stock\nAkeso (SEHK:9926) has kicked off a Phase III trial of cadonilimab in resectable MSI-H/dMMR colon cancer, marking a new indication that could reshape expectations for its immuno-oncology portfolio.\nAkeso shares have picked up momentum in recent months, with a 16.56% 1 month share price return and 12.19% 3 month share price return at a last close of HK$109.1. However, the 1 year total shareholder return declined 14.77%, even as the 3 year total...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/is-akeso-sehk9926-cheap-as-its-phase-iii-colon-cancer-trial","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/is-akeso-sehk9926-cheap-as-its-phase-iii-colon-cancer-trial","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1794554557.SGD","LU2476274720.SGD","KURE","LU2488822045.USD","LU0348784397.USD","LU0561508036.HKD","LU1961090484.USD","LU0348767384.USD","LU0348825331.USD","LU2399975544.HKD","LU2778985437.USD","LU2476274308.USD","BK1574","IE00BPRC5H50.USD","LU0417516571.SGD","LU0417516902.SGD","LU0348827113.USD","IE00B543WZ88.USD","LU0417516738.SGD","09926","LU0348783233.USD","LU0634319403.HKD","LU0348766576.USD","BK1161","LU1720050803.USD","LU0348735423.USD","LU0540923850.HKD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674895664","title":"Akeso Doses First Patient in Phase III Cadonilimab Perioperative Trial for MSI-H/dMMR Colon Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674895664","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674895664?lang=en_us&edition=fundamental","pubTime":"2026-10-10 12:41","pubTimestamp":1791607307,"startTime":"0","endTime":"0","summary":"Akeso doses first patient in Phase III cadonilimab perioperative trial for MSI-H/dMMR colon cancerAkeso dosed the first patient in a Phase III perioperative trial of cadonilimab for resectable MSI-H o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261010:nNDL6m5sjr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","KURE","LU0417516902.SGD","LU0417516738.SGD","LU2778985437.USD","LU0348827113.USD","LU2476274308.USD","LU0561508036.HKD","LU0417516571.SGD","LU1794554557.SGD","BK1161","LU0348766576.USD","LU0348784397.USD","LU0348767384.USD","IE00B5MMRT66.SGD","09926","IE00B543WZ88.USD","LU0348825331.USD","LU2476274720.SGD","LU0348735423.USD","LU1961090484.USD","LU0348783233.USD","IE00BPRC5H50.USD","LU2399975544.HKD","LU1720050803.USD","LU2488822045.USD","LU0634319403.HKD","LU0540923850.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674260831","title":"WuXi Biologics Showcases Biomanufacturing Capabilities at CPHI Milan 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2674260831","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674260831?lang=en_us&edition=fundamental","pubTime":"2026-10-09 15:45","pubTimestamp":1791531907,"startTime":"0","endTime":"0","summary":"WuXi Biologics showcases biomanufacturing capabilities at CPHI Milan 2026WuXi Biologics attended CPHI Milan 2026, meeting biopharma partners to promote its integrated CRDMO platform for complex biolog","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDL9J2Wpn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518931.SGD","LU0326950275.SGD","BK1610","LU0823426308.USD","LU0052750758.USD","SG9999002463.SGD","LU2476274720.SGD","LU0417516738.SGD","LU0128522744.USD","LU0140636845.USD","LU0516423174.USD","LU0516422440.USD","LU0856984785.SGD","LU0417516902.SGD","LU1720050803.USD","LU0043850808.USD","SG9999002562.SGD","LU1880383366.USD","LU0181495838.USD","LU2039709279.SGD","LU1688375341.USD","LU0320764599.SGD","BK1521","02269","LU0211977185.USD","LU0359201612.USD","LU0708995583.HKD","LU0823426480.USD","LU1242518857.USD","LU0634319403.HKD","BK1141","LU0029874061.USD","IE00B0JY6N72.USD","LU2778985437.USD","LU0307460666.USD","LU1794554557.SGD","LU0128526141.USD","LU0979878070.USD","LU0456846285.SGD","BK1589","LU0327786744.USD","LU0359202008.SGD","LU3063872942.SGD","LU0456827905.SGD","LU0708995153.HKD","LU2476274308.USD","LU0320764243.SGD","KURE","LU0348825331.USD","LU0572944931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674988886","title":"Innovent Announces Phase 3 Restore-3 Study of Sycume® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2674988886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674988886?lang=en_us&edition=fundamental","pubTime":"2026-10-09 08:00","pubTimestamp":1791504000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nTUA66SJGY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0502904849.HKD","LU2097828557.USD","LU2488822045.USD","LU0455707207.USD","LU2097828631.EUR","BK1583","LU2097828714.EUR","LU2097828805.USD","LU2328871848.SGD","KURE","LU0463099449.HKD","HK0000165453.HKD","LU1188198961.HKD","BK1161","LU2097828474.EUR","LU0607220059.USD","01801","LU0244354667.USD","LU1969619763.USD","LU1831875114.USD","LU0149534421.HKD","LU0326950275.SGD","BK1589","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/KURE\",params:#limit:6,delay:false,,,undefined,":[]}}